106 related articles for article (PubMed ID: 8387687)
1. Induction chemotherapy for stage IIIA unresectable non-small cell lung cancer: the Toronto experience and an overview.
Goldberg M; Burkes RL
Semin Surg Oncol; 1993; 9(2):108-13. PubMed ID: 8387687
[TBL] [Abstract][Full Text] [Related]
2. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial.
Burkes RL; Ginsberg RJ; Shepherd FA; Blackstein ME; Goldberg ME; Waters PF; Patterson GA; Todd T; Pearson FG; Cooper JD
J Clin Oncol; 1992 Apr; 10(4):580-6. PubMed ID: 1312587
[TBL] [Abstract][Full Text] [Related]
3. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
4. Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients.
Martini N; Kris MG; Flehinger BJ; Gralla RJ; Bains MS; Burt ME; Heelan R; McCormack PM; Pisters KM; Rigas JR
Ann Thorac Surg; 1993 Jun; 55(6):1365-73; discussion 1373-4. PubMed ID: 8390230
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial.
Burkes RL; Shepherd FA; Blackstein ME; Goldberg ME; Waters PF; Patterson GA; Todd T; Pearson FG; Jones D; Farooq S; McGlaughlin J; Ginsberg RJ
Lung Cancer; 2005 Jan; 47(1):103-9. PubMed ID: 15603860
[TBL] [Abstract][Full Text] [Related]
6. [A pilot study of induction chemotherapy with cisplatin, mitomycin C and vindesine for stage III N2 non-small cell lung cancer].
Nishiwaki Y; Nagai K; Kodama T; Nishiyama H; Hojo H; Matsumoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():203-11. PubMed ID: 8007467
[TBL] [Abstract][Full Text] [Related]
7. Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group.
Vansteenkiste JF; De Leyn PR; Deneffe GJ; Lievens YN; Nackaerts KL; Van Raemdonck DE; van der Schueren E; Lerut TE; Demedts MG
Ann Oncol; 1998 Mar; 9(3):261-7. PubMed ID: 9602259
[TBL] [Abstract][Full Text] [Related]
8. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
Scagliotti GV; Fossati R; Torri V; Crinò L; Giaccone G; Silvano G; Martelli M; Clerici M; Cognetti F; Tonato M;
J Natl Cancer Inst; 2003 Oct; 95(19):1453-61. PubMed ID: 14519751
[TBL] [Abstract][Full Text] [Related]
9. [Surgical treatment of non-small cell lung cancer with mediastinal node invasion. A retrospective study].
Arnau Obrer A; Martín Díaz E; Pérez Alonso D; Regueiro Mira F; Cervera Juan A; Granell Gil M; Roch Pendería S; Cantó Armengod A
Arch Bronconeumol; 2001 Mar; 37(3):121-6. PubMed ID: 11333537
[TBL] [Abstract][Full Text] [Related]
10. Pre-operative chemotherapy for stage IIIa (N2) non-small cell lung cancer.
Chella A; Lucchi M; Ribechini A; Silvano G; Mussi A; Janni A; Angeletti CA
Eur J Surg Oncol; 1995 Aug; 21(4):393-7. PubMed ID: 7664906
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase 2 evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine, and cisplatin in patients with technically unresectable stage IIIA and IIIB non-small cell cancer of the lung. LCSG 881.
Wagner H; Lad T; Piantadosi S; Ruckdeschel JC
Chest; 1994 Dec; 106(6 Suppl):348S-354S. PubMed ID: 7988262
[TBL] [Abstract][Full Text] [Related]
13. Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
Gebbia V; Galetta D; Riccardi F; Gridelli C; Durini E; Borsellino N; Gebbia N; Valdesi M; Caruso M; Valenza R; Pezzella G; Colucci G;
Lung Cancer; 2002 Aug; 37(2):179-87. PubMed ID: 12140141
[TBL] [Abstract][Full Text] [Related]
14. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
[TBL] [Abstract][Full Text] [Related]
15. Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
Wada H; Miyahara R; Tanaka F; Hitomi S
Eur J Cardiothorac Surg; 1999 Apr; 15(4):438-43. PubMed ID: 10371118
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma.
Ng KK; Kris MG; Ginsberg RJ; Heelan RT; Pisters KM; Miller VA; Grant SC; Bains M; Rusch V; Rosenzweig KE; Martini N
Cancer; 1999 Oct; 86(7):1189-97. PubMed ID: 10506703
[TBL] [Abstract][Full Text] [Related]
17. [Surgery and combined therapy for non-small cell lung cancer with invasion of the mediastinal nodes. A retrospective study].
Arnau Obrer A; Martín Díaz E; Pérez Alonso D; Regueiro Mira F; Cañizares Carretero M; Cervera Juan A; Granell Gil M; Roch Tejerina S; Cantó Armengod A
Arch Bronconeumol; 2001 Apr; 37(4):160-5. PubMed ID: 11412499
[TBL] [Abstract][Full Text] [Related]
18. Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials.
Pisters KM; Kris MG; Gralla RJ; Zaman MB; Heelan RT; Martini N
J Clin Oncol; 1993 Sep; 11(9):1757-62. PubMed ID: 8394881
[TBL] [Abstract][Full Text] [Related]
19. Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC).
Lee SW; Choi EK; Chung WK; Shin KH; Ahn SD; Kim JH; Kim SW; Suh C; Lee JS; Kim WS; Kim DS; Kim DK; Park SI; Sohn KH
Lung Cancer; 2002 Jul; 37(1):65-71. PubMed ID: 12057869
[TBL] [Abstract][Full Text] [Related]
20. Induction chemotherapy for T4 centrally located non-small cell lung cancer.
Rendina EA; Venuta F; De Giacomo T; Ciccone AM; Ruvolo G; Coloni GF; Ricci C
J Thorac Cardiovasc Surg; 1999 Feb; 117(2):225-33. PubMed ID: 9918961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
